Javascript must be enabled to use this form.

View Profile	Home Browse Faculty Facility Research Consortia Training Grants Courses Search Support About rSp Help and FAQ's Contact Us	GCC Home
Faculty Profile Last Modified Time: 09:06:56 AM Wed, 15 Apr 2020   Contact Information Funda Meric-Bernstam Associated Profiles  Department Chair, Investigational Cancer Therapeutics, Medical Director, Khalifa Institute for Personalized Cancer Therapy, Nellie B. Connally Chair in Breast Cancer Research, Professor, Surgical Oncology, UT MD Anderson Cancer Center   MDA FC8.3044, Room No.: Unit 455    fmeric@mdanderson.org     713-745-4453    Web Link    Breast Neoplasms, Neoplasms, Mutation, Breast, Recurrence, Survival, Drug Therapy, Therapeutics    Associated Profiles Research and Expertise Affiliations Appointments  Research and Expertise Research Interests   Funda Meric-Bernstam, MD, is Chair of the Department of Investigational Cancer Therapeutics, Medical Director of the Institute for Personalized Cancer Therapy (IPCT), and a Professor in the Divisions of Cancer Medicine and Surgery at MD Anderson Cancer Center. Her basic and translational research focuses on molecular therapeutics, predominantly on PI3K/Akt/mTOR signaling, to delineate the mechanism of action agents targeting this pathway and the molecular alterations to identify patients who will benefit from each agent, and combination therapies. Her research seeks to identify molecular markers for predisposition testing, disease screening and prognostic assessment, as well as markers to predict and monitor drug response. As Medical Director of the IPCT, she leads large genomic testing efforts; helped build a framework to assess actionability of genomic alterations; established a Precision Oncology Decision Support Team that provides input for actionability; launched the personalizedcancertherapy.org website, which provides information on therapeutic relevance of specific genes/variants; created databases and alert systems to facilitate accrual to genotype-selected trials; and monitors trial enrollment after genomic testing. She leads and participates in investigator-initiated trials, cooperative group trials, and industry sponsored trials, ranging from window-of-opportunity trials, neoadjuvant therapy trials, and Phase I/II trials in advanced cancers, as well as trials of new surgical techniques, imaging devices, and molecular diagnostics.  Publications/Creative Works Click here to search for this faculty member's publications on PubMed.  Affiliations  Training Grants NLM Training Program in Biomedical Informatics & Data Science for Predoctoral and Postdoctoral Fellows  Appointments Title Department / School Institution Department Chair Investigational Cancer Therapeutics MD Anderson Cancer Center Medical Director Khalifa Institute for Personalized Cancer Therapy MD Anderson Cancer Center Nellie B. Connally Chair Breast Cancer Research MD Anderson Cancer Center Professor Surgical Oncology MD Anderson Cancer Center

powering - The Partnership
Important Disclaimer: The responsibility for the accuracy of the information contained on these pages lies with the authors and user providing such information.